For the first time, patients whose prostate cancer has not spread will be eligible for the drug abiraterone in England, after ...

A research team at the University of Würzburg has, for the first time, uncovered how E. coli bacteria sneak into the prostate ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...

Prostate cancer, a common malignancy in men, can rarely spread to the skin, a condition known as cutaneous metastasis. These skin lesions, often appearing in later stages, may manifest as nodules, ...

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

Prostate cancer is a significant health concern for men worldwide, with increasing diagnoses and fatalities projected. Early detection and treatment are crucial, as the disease often presents no ...

Prostate Cancer Awareness Month is observed every September to raise awareness about prostate cancer, the second most common cancer in men worldwide. This month serves as an opportunity to educate the ...

A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence, Swedish ...

Prostate cancer cases have been on the rise in recent years, increasing 3% annually since 2014 – and now former President Joe Biden is one of the more than 300,000 men to be diagnosed this year. Biden ...